Navigation Links
BioSpecifics Announces Positive Results From Clinical Trial in Canine Lipomas
Date:1/6/2011

3/4 of the dose used in previous human clinical trials. Based on this dose escalation study the Company selected the dose for Chien-802.

Chien-802 was designed to evaluate the efficacy of injectable collagenase in canine lipoma in four healthy dogs with subcutaneous lipomas. Inclusion criteria required the lipoma to be benign, superficial and easily measureable. All dogs had a second lipoma that was untreated and used as a control. At 90 days post injection, in the three evaluable dogs, the lipoma size was 0%, 0% or 7% of the original size as measured by a CT scan. By contrast, the untreated lipomas were 129%, 113% and 128% of the original size at day 90. Thus, the treated lipomas showed a 97% reduction in the size of the lipoma and an increase in the size of the untreated controls of 23%.  Based on the positive results from Chien-802, BioSpecifics has begun enrollment in a randomized, double-blind, placebo-controlled study designed to evaluate the efficacy of purified collagenase for injection for the treatment of canine lipomas.

The Company's preliminary results from an ongoing marketing survey indicate that veterinarians perform lipoma excision surgery on an average of 25 dogs per year, costing approximately $635 million annually.  

The American Veterinary Medical Association estimates that 47,000 veterinarians practice on small animals. Based on the data from BioSpecifics' survey of veterinarians, the veterinarians estimate that they would use injectable collagenase on an average of 22 dogs per year. BioSpecifics believes that the total potential market for purified collagenase for the treatment of canine lipomas could be 1 million injections in the Unites States annually.

BioSpecifics' strategic partner, Auxilium Pharmaceuticals, Inc. (Auxilium), has the option to license development and marketing rights to this indication, which would trigger an opt-in payment and potential future milestone payments from Auxilium t
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. BioSpecifics Technologies Corp. to Present at UBS Global Life Sciences Conference
2. BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 12th Annual Healthcare Conference
3. Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
4. BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
5. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2009 Financial Results on November 5, 2009
6. BioSpecifics Technologies Corp. Stock Trading Halted Today
7. BioSpecifics Technologies Corp. To Present at BioCentury NewsMakers in the Biotech Industry Conference
8. BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 11th Annual Healthcare Conference
9. BioSpecifics Technologies Corp. Reports Second Quarter 2009 Financial Results
10. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009
11. BioSpecifics Technologies Corp. to Present at CapStone Investments Third Annual Small-Cap Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Madison, WI (PRWEB) May 24, 2013 ... to the discovery and development of calcium-binding proteins ... publication of safety assessment study of apoaequorin ... an international journal published for the British Industrial ... the study was to investigate potential adverse effects, ...
(Date:5/23/2013)... Can economic incentives such as gift cards, ... the public to increase their donations of blood? , ... Business School Assistant Professor Mario Macis says the ... body of recent research that supports their argument, the ... of Science that the World Health Organization and national ...
(Date:5/23/2013)... 2013 The maker community is a ... inventions. They focus on learning practical skills while applying ... toward bringing their ideas to life via crowdfunding. A ... on making projects using biology. Glowing Plant has worked ... make them glow with bioluminescence genes, and has now ...
(Date:5/23/2013)... 23, 2013 BioTrends Research Group, one ... for specialized biopharmaceutical issues, finds that, unaided, one ... specialists reported that in the past six months, ... treatment) in anticipation of the next generation of ... when only 6 percent reported that they had ...
Breaking Biology Technology:Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3
... Journal Indicates Masimo SET May Also Reduce the Need for ... Jan. 30 Masimo (Nasdaq: ... Motion and Low Perfusion pulse oximetry, today announced that a ... January 2009 issue of the British Medical Journal ...
... Stock Exchange Symbol: MSEDMONTON, Jan. 30 /PRNewswire-FirstCall/ - ... in the treatment of multiple sclerosis (MS), today ... clinical trial evaluating dirucotide in patients with relapsing-remitting ... is for secondary progressive MS where it is ...
... CA The logic and memory functions of future electronic ... (billionths of a meter) instead of the many tens of ... way can be found to control domain walls, the ultrathin ... magnetic, electric, or other properties. , In a ...
Cached Biology Technology:New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns 2New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns 3New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns 4New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns 5BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis 2BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis 3BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis 4BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis 5Domain walls that conduct electricity 2Domain walls that conduct electricity 3Domain walls that conduct electricity 4Domain walls that conduct electricity 5
(Date:5/23/2013)... Public Health at Emory University, along with partners ... a $4 million grant over four years to ... and Exposome Research Center: Understanding Lifetime Exposures). The ... in the United States. , The HERCULES ... Environmental Health Sciences (NIEHS) of the National Institutes ...
(Date:5/23/2013)... wrapping of genomic DNA around nucleosomes in the ... A team of Ludwig-Maximilians-Universitaet (LMU) in Munich now ... be locally displaced from nucleosomes for transcription. , ... in the cell nucleus, wrapped around disk-shaped particles ... four different histone proteins and accommodating two loops ...
(Date:5/23/2013)... unnecessarily undergo surgery or harsh treatments because science ... aggressive forms of the disease. Researchers at Case ... are developing technology that allows patients to safely ... treatments or take drastic measures. , The project ... professor of biomedical engineering at Case Western Reserve ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Biochemistry: Unspooling DNA from nucleosomal disks 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3
... healthy men decline as they get older. As sleep ... in the amount of sleep a healthy older man gets ... to a study published in the April 1st issue of ... MD, PhD, of the University of Chicago, focused on 12 ...
... state-of-the-art technique to map neurons in the spinal cord ... a surprising pattern of activity that regulates the speed ... implications for treating injured human spinal cords and Parkinson’s ... The study, "A Topographic Map of Recruitment in Spinal ...
... delivery system using microspheres of a biodegradable polymer may not ... but also appears to stimulate an immune response that traditional ... their findings today at the ASM Biodefense and Emerging Disease ... that block entry into the cell. In the case ...
Cached Biology News:Fast and slow -- How the spinal cord controls the speed of movement 2Biodegradable microspheres deliver time release vaccines, stimulate different immune response 2
In Western blotting antibodies recognize 94 K protein band, which corresponds to S-layer protein...
... is based on the simple, highefficiency Tn5 ... and Reznikoff, and by York et al. ... and inversions by intramolecular transposition into DNA ... Although most researchers will be interested in ...
High affinity antibodies recognizes HSP70 protein from human cardiac tissue. Could be used for Westerb blotting application, ELISA....
... knockout or alter genes on the E.coli ... recombination allows the exchange of genetic information in ... An FRT-flanked kanamycin resistance marker cassette is supplied ... replace a gene on the E.coli ...
Biology Products: